Sign in

MCTA on Nasdaq

Charming Medical Ltd

Misc health and allied services company based in Hong Kong1

In its 2026 annual report (Form 20-F) the company says: “It is a holding company with no material operations of its own, and it conducts all of its operations in Hong Kong through its Operating Subsidiaries, namely Pilate International Trading Limited, My Beauty Technology Limited, Dream International Trading (Hong Kong) Limited and Choliya Limited, held through intermediate holding company, Beautylab Group Medical Limited.”4 Its shares trade on Nasdaq under the symbol MCTA.1

Price unavailable

Last updated Oct 21, 2026.

Overview

$4.8MRevenue, fiscal 20262
-$22.6KNet income, fiscal 20262

Compare with NewGenIvf Group Ltd, PACIFIC HEALTH CARE ORGANIZATION INC or Marpai, Inc., or pick any stock.

  • TickerMCTA on Nasdaq1
  • IndustryServices-Misc Health & Allied Services, NEC1
  • HeadquartersHong Kong, Hong Kong1
  • Business addressUnits 1803-1U806, 18/F, Hang Lung Centre, 2-20 Paterson Street, Causeway Bay, Hong Kong, K3 000003
  • Filer categoryNon-accelerated filer, Emerging growth company3

See how the biggest companies compare on our leaderboards

Charming Medical Limited was incorporated in the British Virgin Islands as a BVI business company with limited liability on February 28, 2024 under the BVI Act. It is a holding company with no material operations of its own, and it conducts all of its operations in Hong Kong through its Operating Subsidiaries, namely Pilate International Trading Limited (“Pilate”), My Beauty Technology Limited (“My Beauty Technology”), Dream International Trading (Hong Kong) Limited (“Dream International Trading”) and Choliya Limited (“Choliya”), held through intermediate holding company, Beautylab Group Medical Limited (“Beautylab BVI”).4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2026

-0.6%Operating margin2
-0.5%Net margin2
-22.7%Revenue growth, 20262
-0.4%Return on equity2
0.04×Debt to equity2
-$1.6MFree cash flow2

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Beauty, Wellness and Postpartum Services brought in 93% of the revenue Charming Medical Ltd broke down this way in fiscal 2026.

  1. Beauty, Wellness and Postpartum Services$4.5M293%down 24% from 2025
  2. Sales Of Products$163.4K23%down 21% from 2025
  3. Franchise$135.8K23%up 191% from 2025
  4. Pre-Opening Service$46.7K21%
Products and services by year
Products and services202420252026
Beauty, Wellness and Postpartum Services$5.8M$6.0M$4.5M
Sales Of Products$89.0K$207.8K$163.4K
Franchise$46.7K$135.8K
Pre-Opening Service$46.7K

Where the money goes

Where each dollar of revenue went, fiscal 2026

  • Cost of revenue1¢$35.2K
  • Other costs96¢$4.6M
  • Interest0¢$15.8K
  • Income tax3¢$156.1K

Out of $4.8M in revenue.2 The company lost money this year.

Financial statements

Revenue2$4.8M in 2026−20% since 2024
0$2.0M$4.0M$6.0M$8.0M2024: $6.0M$6.0M20242025: $6.2M$6.2M2025+3%2026: $4.8M$4.8M2026−23%
Operating income2-$29.2K in 2026
-$500.0K0$500.0K$1.0M$1.5M2024: $1.0M$1.0M20242025: $1.4M$1.4M2025+38%2026: -$29.2K-$29.2K2026
Net income2-$22.6K in 2026
-$500.0K0$500.0K$1.0M$1.5M2024: $777.8K$777.8K20242025: $1.2M$1.2M2025+54%2026: -$22.6K-$22.6K2026

Every line of the income statement as filed: the last 3 fiscal years, latest first.2

Period ending2026-03-312025-03-312024-03-31
TOTAL REVENUES$4.8M$6.2M$6.0M
Cost of sales of products$35.2K$15.5K$11.3K
Advertising and promotion expenses$803.5K$999.4K$859.5K
Staff Costs and Employee Benefits$1.6M$1.8M$1.9M
Rental and Building Management Expenses$551.4K$711.7K$848.7K
Professional expenses$782.4K$173.1K$260.2K
Depreciation$216.1K$263.5K$391.7K
Bank charges$137.7K$210.7K$163.7K
Consumables$139.8K$186.1K$159.2K
Other general and administrative expenses$546.9K$433.1K$381.3K
TOTAL OPERATING EXPENSES$4.8M$4.8M$5.0M
(LOSS) INCOME FROM OPERATIONS-$29.2K$1.4M$1.0M
Interest income$72.7K$64.1K$19.5K
Interest expense-$15.8K-$20.9K-$26.1K
Unrealized gain from investments, net$22.6K$2.6K
Realized gain from investments$12.1K
Government subsidies$20.4K$15.5K$1.4K
Other income (expense)$50.8K-$15.1K-$214
TOTAL OTHER INCOME (EXPENSE), NET$162.7K$46.2K-$5.4K
INCOME BEFORE INCOME TAX$133.5K$1.4M$1.0M
INCOME TAX EXPENSES$156.1K$236.1K$181.8K
NET (LOSS) INCOME-$22.6K$1.2M$821.7K
Less: Net income attributable to non-controlling interests-$43.9K
Net (loss) income attributable to the shareholders of the Company-$22.6K$1.2M$777.8K
Foreign currency translation adjustment-$11.2K-$3.8K-$3.7K
Non-controlling interests-$348
TOTAL OTHER COMPREHENSIVE LOSS-$11.2K-$3.8K-$4.1K
TOTAL COMPREHENSIVE (LOSS) INCOME-$33.9K$1.2M$817.7K
(Loss) earnings per share, Basic$0.00$0.08$0.05
(Loss) earnings per share, diluted$0.00$0.08$0.05
Weighted average number of ordinary shares, Basic16.2M shares15.3M shares15.3M shares
Weighted average number of ordinary shares, diluted16.2M shares15.3M shares15.3M shares

Compare Charming Medical Ltd with another company

Corporate structure

Charming Medical Ltd sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Charming Medical Ltd

  • Charming Medical Ltd Hong Kong, Hong Kong

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Charming Medical Ltd reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$1.5M2 Mar 31, 2026$1.4M2 Mar 31, 2025+4.9%
Accumulated depreciation$844.4K2 Mar 31, 2026$883.8K2 Mar 31, 2025−4.5%
Property and equipment, net$606.9K2 Mar 31, 2026$500.1K2 Mar 31, 2025+21.4%
Operating-lease assets (leased space)$724.1K2 Mar 31, 2026$710.5K2 Mar 31, 2025+1.9%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$4.7M2 Mar 31, 2026$816.8K2 Mar 31, 2025+475.3%

Inventory

ItemLatestA year beforeChange
Inventory, total$25.6K2 Mar 31, 2026$26.8K2 Mar 31, 2025−4.4%

Leadership

Who has led Charming Medical Ltd, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Kit Christine Wong2026–now

Chief financial officer

  1. Ching Man Cheung2026–now
Board members and other officers (1)

Timeline

  1. Mar 27, 2026New chief executive Kit Christine Wong becomes CEO5

Filings

37 filings to the SEC since October 2021: 1 annual reports, 3 insider forms, 1 large holders, 32 other. The latest 20:

  1. Sep 29, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  2. Jul 30, 202620-F ANNUAL REPORT EDGAR
  3. Jul 21, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  4. May 6, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  5. Apr 2, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  6. Mar 31, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  7. Mar 27, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  8. Mar 27, 2026SCHEDULE 13D EDGAR
  9. Mar 27, 20263 EDGAR
  10. Mar 27, 20263 EDGAR
  11. Mar 27, 20263 EDGAR
  12. Jan 6, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  13. Nov 28, 20256-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  14. Nov 13, 20256-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  15. Oct 28, 20256-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  16. Oct 22, 20256-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  17. Oct 21, 2025424B4 PROSPECTUS EDGAR
  18. Oct 20, 2025CERT EDGAR
  19. Oct 20, 20258-A12B FOR REGISTRATION OF CERTAIN CLASSES EDGAR
  20. Sep 30, 2025EFFECT EDGAR

The 37 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Charming Medical Ltd is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARCharming Medical Ltd1
  • CIK0002035992
  • Filer statusNon-accelerated filer an emerging growth company; not a shell company4
  • Incorporated inD84
  • Industry code (SIC)8090 Services-Misc Health & Allied Services, NEC1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business addressUnits 1803-1U806, 18/F, Hang Lung Centre, 2-20 Paterson Street, Causeway Bay, Hong Kong, K3 000001
  • Phone852 2116 14921
  • Shares outstanding15,178,000 Common Class A shares; 2,000,000 Common Class B shares as of Mar 31, 20264
  • AuditorWWC, P.C., San Mateo, California PCAOB ID 1171; no auditor attestation of internal control over financial reporting4
  • On EDGAR sinceNov 21, 20241
  • Filings37 in all: 6-K (11), 3 (3), CORRESP (3), F-1/A (3), UPLOAD (3), DRS/A (2), DRSLTR (2), FWP (2)1
    All 16 form types

    20-F (1), 424B4 (1), 8-A12B (1), CERT (1), DRS (1), EFFECT (1), F-1 (1), SCHEDULE 13D (1)

  • Latest filingsAnnual report (20-F) Jul 30, 2026

Securities registered for trading

ClassSymbolExchange
Class A Ordinary Shares, par value $0.0001 per shareMCTAThe Nasdaq Stock Market LLC

From the cover page of the 20-F filed Jul 30, 2026 (Section 12(b) of the Exchange Act).4

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7